Allarity-backed SPAC files S-1 for $100M IPO
Allarity Therapeutics said a SPAC sponsor filed an S-1 for a proposed $100 million IPO, with up to $115 million including overallotment. The sponsor is expected to own about 25% after the offering.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.